Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs S-1/CDDP vs 5-FU/CDDP in Advanced Gastric Cancer
NCT00202969Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Jul 2005; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00202969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202969.